TY - JOUR AU - Maroz, N. AU - Segal, M. S. PY - 2013 DA - 2013// TI - Lupus nephritis and end-stage kidney disease JO - Am J Med Sci VL - 346 UR - https://doi.org/10.1097/MAJ.0b013e31827f4ee3 DO - 10.1097/MAJ.0b013e31827f4ee3 ID - Maroz2013 ER - TY - JOUR AU - Xing, Q. AU - Wang, B. AU - Su, H. AU - Cui, J. AU - Li, J. PY - 2012 DA - 2012// TI - Elevated Th17 cells are accompanied by FoxP3+ Treg cells decrease in patients with lupus nephritis JO - Rheumatol Int VL - 32 UR - https://doi.org/10.1007/s00296-010-1771-0 DO - 10.1007/s00296-010-1771-0 ID - Xing2012 ER - TY - JOUR AU - Zhu, M. AU - Mo, H. AU - Li, D. AU - Luo, X. AU - Zhang, L. PY - 2013 DA - 2013// TI - Th17/Treg imbalance induced by increased incidence of atherosclerosis in patients with systemic lupus erythematosus (SLE) JO - Clin Rheumatol VL - 32 UR - https://doi.org/10.1007/s10067-013-2237-z DO - 10.1007/s10067-013-2237-z ID - Zhu2013 ER - TY - JOUR AU - Katsuyama, T. AU - Tsokos, G. C. AU - Moulton, V. R. PY - 2018 DA - 2018// TI - Aberrant T cell signaling and subsets in systemic lupus erythematosus JO - Front Immunol VL - 9 UR - https://doi.org/10.3389/fimmu.2018.01088 DO - 10.3389/fimmu.2018.01088 ID - Katsuyama2018 ER - TY - JOUR AU - Freitas, E. C. AU - Oliveira, M. S. AU - Monticielo, O. A. PY - 2017 DA - 2017// TI - Pristane-induced lupus: considerations on this experimental model JO - Clin Rheumatol VL - 36 UR - https://doi.org/10.1007/s10067-017-3811-6 DO - 10.1007/s10067-017-3811-6 ID - Freitas2017 ER - TY - JOUR AU - Chae, B. S. AU - Shin, T. Y. PY - 2007 DA - 2007// TI - Immunoregulatory abnormalities of T cells and hyperreactivity of B cells in the in vitro immune response in pristane-induced lupus mice JO - Arch Pharm Res VL - 30 UR - https://doi.org/10.1007/BF02977694 DO - 10.1007/BF02977694 ID - Chae2007 ER - TY - JOUR AU - Jayawardena, D. AU - Guzman, G. AU - Gill, R. K. AU - Alrefai, W. A. AU - Onyuksel, H. AU - Dudeja, P. K. PY - 2017 DA - 2017// TI - Expression and localization of VPAC1, the major receptor of vasoactive intestinal peptide along the length of the intestine JO - Am J Physiol Gastrointest Liver Physiol VL - 313 UR - https://doi.org/10.1152/ajpgi.00081.2017 DO - 10.1152/ajpgi.00081.2017 ID - Jayawardena2017 ER - TY - JOUR AU - Kasacka, I. AU - Piotrowska, Ż. AU - Janiuk, I. PY - 2015 DA - 2015// TI - Influence of renovascular hypertension on the distribution of vasoactive intestinal peptide in the stomach and heart of rats JO - Exp Biol Med VL - 240 UR - https://doi.org/10.1177/1535370215587533 DO - 10.1177/1535370215587533 ID - Kasacka2015 ER - TY - JOUR AU - Deng, G. AU - Jin, L. PY - 2017 DA - 2017// TI - The effects of vasoactive intestinal peptide in neurodegenerative disorders JO - Neurol Res VL - 39 UR - https://doi.org/10.1080/01616412.2016.1250458 DO - 10.1080/01616412.2016.1250458 ID - Deng2017 ER - TY - JOUR AU - Benitez, R. AU - Delgado-Maroto, V. AU - Caro, M. AU - Forte-Lago, I. AU - Duran-Prado, M. AU - O'Valle, F. AU - Lichtman, A. H. AU - Gonzalez-Rey, E. AU - Delgado, M. PY - 2018 DA - 2018// TI - Vasoactive intestinal peptide ameliorates acute myocarditis and atherosclerosis by regulating inflammatory and autoimmune responses JO - J Immunol VL - 200 UR - https://doi.org/10.4049/jimmunol.1800122 DO - 10.4049/jimmunol.1800122 ID - Benitez2018 ER - TY - JOUR AU - Villanueva-Romero, R. AU - Gutiérrez-Cañas, I. AU - Carrión, M. AU - Pérez-García, S. AU - Seoane, I. V. AU - Martínez, C. AU - Gomariz, R. P. AU - Juarranz, Y. PY - 2018 DA - 2018// TI - The anti-inflammatory mediator, vasoactive intestinal peptide, modulates the differentiation and function of th subsets in rheumatoid arthritis JO - J Immunol Res VL - 2018 ID - Villanueva-Romero2018 ER - TY - JOUR AU - Li, C. AU - Zhu, F. AU - Wu, B. AU - Wang, Y. PY - 2018 DA - 2018// TI - Vasoactive intestinal peptide protects salivary glands against structural injury and secretory dysfunction via IL-17A and AQP5 regulation in a model of Sjögren syndrome JO - Neuroimmunomodulation VL - 24 UR - https://doi.org/10.1159/000486859 DO - 10.1159/000486859 ID - Li2018 ER - TY - JOUR AU - Pozo, D. AU - Anderson, P. AU - Gonzalez-Rey, E. PY - 2009 DA - 2009// TI - Induction of alloantigen-specific human T regulatory cells by vasoactive intestinal peptide JO - J Immunol VL - 183 UR - https://doi.org/10.4049/jimmunol.0900400 DO - 10.4049/jimmunol.0900400 ID - Pozo2009 ER - TY - JOUR AU - Han, S. AU - Zhuang, H. AU - Yuan, X. AU - Lee, P. AU - Yi, L. AU - Wilson, J. C. AU - Vidal, O. AU - Hong, S. C. AU - Yu, S. AU - Yang, L. J. PY - 2015 DA - 2015// TI - Maintenance of autoantibody production in pristane-induced murine lupus JO - Arthritis Res Ther VL - 17 UR - https://doi.org/10.1186/s13075-014-0514-0 DO - 10.1186/s13075-014-0514-0 ID - Han2015 ER - TY - JOUR AU - You, Y. AU - Qin, Y. AU - Lin, X. AU - Yang, F. AU - Li, J. AU - Sooranna, S. R. AU - Pinhu, L. PY - 2015 DA - 2015// TI - Methylprednisolone attenuates lipopolysaccharide-induced fractalkine expression in kidney of lupus-prone MRL/lpr mice through the NF-kappaB pathway JO - BMC Nephrol VL - 16 UR - https://doi.org/10.1186/s12882-015-0145-y DO - 10.1186/s12882-015-0145-y ID - You2015 ER - TY - JOUR AU - Bluestone, J. A. AU - Liu, W. AU - Yabu, J. M. AU - Laszik, Z. G. AU - Putnam, A. AU - Belingheri, M. AU - Gross, D. M. AU - Townsend, R. M. AU - Vincenti, F. PY - 2008 DA - 2008// TI - The effect of costimulatory and interleukin 2 receptor blockade on regulatory T cells in renal transplantation JO - Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surg VL - 8 UR - https://doi.org/10.1111/j.1600-6143.2008.02377.x DO - 10.1111/j.1600-6143.2008.02377.x ID - Bluestone2008 ER - TY - JOUR AU - Satoh, M. AU - Reeves, W. H. PY - 1994 DA - 1994// TI - Induction of lupus-associated autoantibodies in BALB/c mice by intraperitoneal injection of pristane JO - J Exp Med VL - 180 UR - https://doi.org/10.1084/jem.180.6.2341 DO - 10.1084/jem.180.6.2341 ID - Satoh1994 ER - TY - JOUR AU - Arbuckle, M. R. AU - McClain, M. T. AU - Rubertone, M. V. AU - Scofield, R. H. AU - Dennis, G. J. AU - James, J. A. AU - Harley, J. B. PY - 2003 DA - 2003// TI - Development of autoantibodies before the clinical onset of systemic lupus erythematosus JO - N Engl J Med VL - 349 UR - https://doi.org/10.1056/NEJMoa021933 DO - 10.1056/NEJMoa021933 ID - Arbuckle2003 ER - TY - JOUR AU - Crispín, J. C. AU - Liossis, S. N. AU - Kistoth, K. AU - Lieberman, L. A. AU - Kyttaris, V. C. AU - Juang, Y. T. AU - Tsokos, G. C. PY - 2010 DA - 2010// TI - Pathogenesis of human systemic lupus erythematosus: recent advances JO - Trends Mol Med VL - 16 UR - https://doi.org/10.1016/j.molmed.2009.12.005 DO - 10.1016/j.molmed.2009.12.005 ID - Crispín2010 ER - TY - JOUR AU - Yang, J. AU - Chu, Y. AU - Yang, X. AU - Gao, D. AU - Zhu, L. AU - Yang, X. AU - Wan, L. AU - Li, M. PY - 2009 DA - 2009// TI - Th17 and natural Treg cell population dynamics in systemic lupus erythematosus JO - Arthritis Rheum VL - 60 UR - https://doi.org/10.1002/art.24499 DO - 10.1002/art.24499 ID - Yang2009 ER - TY - JOUR AU - Delgado, M. AU - Ganea, D. PY - 2013 DA - 2013// TI - Vasoactive intestinal peptide: a neuropeptide with pleiotropic immune functions JO - Amino Acids VL - 45 UR - https://doi.org/10.1007/s00726-011-1184-8 DO - 10.1007/s00726-011-1184-8 ID - Delgado2013 ER - TY - JOUR AU - Forghani, P. AU - Petersen, C. T. AU - Waller, E. K. PY - 2017 DA - 2017// TI - Activation of VIP signaling enhances immunosuppressive effect of MDSCs on CMV-induced adaptive immunity JO - Oncotarget VL - 8 UR - https://doi.org/10.18632/oncotarget.20704 DO - 10.18632/oncotarget.20704 ID - Forghani2017 ER - TY - JOUR AU - Shi, H. AU - Carion, T. W. AU - Jiang, Y. AU - Steinle, J. J. AU - Berger, E. A. PY - 2016 DA - 2016// TI - VIP protects human retinal microvascular endothelial cells against high glucose-induced increases in TNF-α and enhances RvD1 JO - Prostaglandins Other Lipid Mediat VL - 123 UR - https://doi.org/10.1016/j.prostaglandins.2016.03.001 DO - 10.1016/j.prostaglandins.2016.03.001 ID - Shi2016 ER - TY - JOUR AU - Gomariz, R. P. AU - Gutiérrez-Cañas, I. AU - Martínez, C. AU - Juarranz, Y. AU - Leceta, J. PY - 2010 DA - 2010// TI - New insights into the role of VIP on the ratio of T-cell subsets during the development of autoimmune diabetes JO - Immunol Cell Biol VL - 88 UR - https://doi.org/10.1038/icb.2010.29 DO - 10.1038/icb.2010.29 ID - Gomariz2010 ER - TY - JOUR AU - Tan, Y. V. AU - Abad, C. AU - Wang, Y. AU - Lopez, R. AU - Waschek, J. PY - 2015 DA - 2015// TI - VPAC2 (vasoactive intestinal peptide receptor type 2) receptor deficient mice develop exacerbated experimental autoimmune encephalomyelitis with increased Th1/Th17 and reduced Th2/Treg responses JO - Brain Behav Immun VL - 44 UR - https://doi.org/10.1016/j.bbi.2014.09.020 DO - 10.1016/j.bbi.2014.09.020 ID - Tan2015 ER - TY - JOUR AU - Ibrahim, H. AU - Barrow, P. AU - Foster, N. PY - 2012 DA - 2012// TI - VIP as a potential therapeutic agent in gram negative sepsis JO - Endocr Metab Immune Disord Drug Targets VL - 12 UR - https://doi.org/10.2174/187153012803832611 DO - 10.2174/187153012803832611 ID - Ibrahim2012 ER - TY - JOUR AU - Jayawardena, D. AU - Anbazhagan, A. N. AU - Guzman, G. AU - Dudeja, P. K. AU - Onyuksel, H. PY - 2017 DA - 2017// TI - Vasoactive intestinal peptide nanomedicine for the management of inflammatory bowel disease JO - Mol Pharm VL - 14 UR - https://doi.org/10.1021/acs.molpharmaceut.7b00452 DO - 10.1021/acs.molpharmaceut.7b00452 ID - Jayawardena2017 ER - TY - JOUR AU - Gonzalez-Rey, E. AU - Fernandez-Martin, A. AU - Chorny, A. AU - Delgado, M. PY - 2006 DA - 2006// TI - Vasoactive intestinal peptide induces CD4+,CD25+ T regulatory cells with therapeutic effect in collagen-induced arthritis JO - Arthritis Rheum VL - 54 UR - https://doi.org/10.1002/art.21652 DO - 10.1002/art.21652 ID - Gonzalez-Rey2006 ER - TY - JOUR AU - Deng, S. AU - Xi, Y. AU - Wang, H. AU - Hao, J. AU - Niu, X. AU - Li, W. AU - Tao, Y. AU - Chen, G. PY - 2010 DA - 2010// TI - Regulatory effect of vasoactive intestinal peptide on the balance of Treg and Th17 in collagen-induced arthritis JO - Cell Immunol VL - 265 UR - https://doi.org/10.1016/j.cellimm.2010.07.010 DO - 10.1016/j.cellimm.2010.07.010 ID - Deng2010 ER -